• Facebook
  • Twitter
Cancer World Archive
  • Magazine
HomeImpact FactorAdjuvant chemotherapy in older patients with breast cancer

Adjuvant chemotherapy in older patients with breast cancer

Agnes Jager, Jaap Verweij and Stefan Sleijfer

1 January 2010 Impact Factor 0

Number 34

Download pdf article

A prospective, randomised trial has shown that standard adjuvant chemotherapy is superior to capecitabine in the treatment of women with breast cancer aged 65 years or older; on the basis of the results of this study, capecitabine cannot be recommended in this setting.

Download full article

  • adjuvant chemotherapy
  • breast cancer
Previous article
Next article

Related Articles

Past events

Lugano (Swi), 6-8/10/2018 – 4th ESO-ESMO Breast Cancer in Young Women International Conference (BCY4)

Past events 10 November 2017 0
Past events

Bratislava (Slovak Republic) 20/05/2016 – 3rd ESO-ESMO Masterclass in Medical Oncology

Past events 2 May 2016 0
News

Linking DNA methylation to Aspirin use and breast cancer survival

News 2 September 2019 0

LATEST PRINTED ISSUE

Latest news

  • Four steps to eliminating HPV infections across Europe: an ECCO call for EU action

    News 16 October 2020 0
    A new report underlines that vaccination, screening, treatment and public awareness, provide the cornerstone for eliminating human papillomavirus (HPV) in Europe. The report was published by The European [more]

Facebook

Twitter

Tweet di @CancerworldESO

© Copyright OncoDaily 2018 with all rights reserved - Credits -


Privacy Policy Cookie Policy